Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
APOE and CYP2E1 polymorphisms, alcohol consumption, and Parkinson's disease in a Japanese population.
Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, Fukushima W, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson’s Disease Study Group. Kiyohara C, et al. J Neural Transm (Vienna). 2011 Sep;118(9):1335-44. doi: 10.1007/s00702-011-0612-y. Epub 2011 Mar 1. J Neural Transm (Vienna). 2011. PMID: 21360299 Free article.
Alcohol drinking and risk of Parkinson's disease: a case-control study in Japan.
Fukushima W, Miyake Y, Tanaka K, Sasaki S, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson's Disease Study Group. Fukushima W, et al. BMC Neurol. 2010 Nov 5;10:111. doi: 10.1186/1471-2377-10-111. BMC Neurol. 2010. PMID: 21054827 Free PMC article.
Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.
Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, Fukushima W, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson's Disease Study Group. Kiyohara C, et al. BMC Neurol. 2011 Jul 25;11:89. doi: 10.1186/1471-2377-11-89. BMC Neurol. 2011. PMID: 21781348 Free PMC article.
[A guideline for the treatment of Parkinson's disease].
Miziuno Y, Okuma Y, Kikuchi S, Kuno S, Hashimoto T, Hasegawa K, Mano Y, Miwa H, Murata M, Yamamoto M, Yokochi F, Okiyama R, Kanazawa A, Shinpo K, Chuma T, Higashi T, Maruyama T, Mizuta E, Yamazaki S; Ad Hoc Committee on the Guidelines for the Treatment of Parkinson's Disease, Japanese Neurological Society. Miziuno Y, et al. Among authors: mizuta e. Rinsho Shinkeigaku. 2002 May;42(5):421-94. Rinsho Shinkeigaku. 2002. PMID: 12708433 Review. Japanese. No abstract available.
Prevention and treatment of malignant syndrome in Parkinson's disease: a consensus statement of the malignant syndrome research group.
Ikebe S, Harada T, Hashimoto T, Kanazawa I, Kuno S, Mizuno Y, Mizuta E, Murata M, Nagatsu T, Nakamura S, Takubo H, Yanagisawa N, Narabayashi H. Ikebe S, et al. Among authors: mizuta e. Parkinsonism Relat Disord. 2003 Apr;9 Suppl 1:S47-9. doi: 10.1016/s1353-8020(02)00123-2. Parkinsonism Relat Disord. 2003. PMID: 12735915 Review.
Biopterin metabolism in patients with malignant syndrome.
Ichinose H, Ohye T, Shinotoh H, Arai K, Yamazaki S, Mizuta E, Kuno S, Nagatsu T. Ichinose H, et al. Among authors: mizuta e. Parkinsonism Relat Disord. 2003 Apr;9 Suppl 1:S11-4. doi: 10.1016/s1353-8020(02)00120-7. Parkinsonism Relat Disord. 2003. PMID: 12735910
123 results